Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET) - Lincoff, AM; Kleiman, NS; Topol, EJ (Am Heart J, 2002)
et al.